Translational Development Acquisition Corp. (TDACW) |
| 1.06 0.01 (0.95%) 05-29 15:51 |
| Open: | 0.325 |
| High: | 1.1 |
| Low: | 0.325 |
| Volume: | 129,073 |
| Market Cap: | 26(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Global Market |
| Industry: | Shell Companies |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 12.61 |
| Resistance 1: | 10.80 |
| Pivot price: | 10.66 |
| Support 1: | 10.69 |
| Support 2: | 10.63 |
| 52w High: | 1.1 |
| 52w Low: | 0.325 |
Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Financials
| EPS | 0.290 |
| Book Value | -0.300 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -0.3 |
| Return on Equity (ttm) | 0.0 |
Company news
Wed, 27 May 2026
ProLogium to list on Nasdaq via TDAC merger at $3.8B valuation - Seeking Alpha
Wed, 27 May 2026
TDAC merges with ProLogium, combined company to list as PRLG (PRLG) - Stock Titan
Wed, 27 May 2026
Solid-state battery maker ProLogium, TDAC (NASDAQ: TDAC) plan $3.8B merger - Stock Titan
Fri, 15 May 2026
Translational Development Acquisition (NASDAQ: TDAC) flags going concern risk as SPAC deadline nears - Stock Titan
Tue, 12 May 2026
Translational Development Acquisition Corp. 2025 Annual Report Amendment: SEC Review, Controls, and Exhibit Certifications - Minichart
Mon, 11 May 2026
Disclosure controls deemed ineffective in TDAC (NASDAQ: TDAC) 10-K/A - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
